PEMBROLIZUMAB

undefined/100 · Low Risk

Manufactured by Merck Sharp & Dohme LLC

152,954 FDA adverse event reports analyzed

Top Adverse Reactions

MALIGNANT NEOPLASM PROGRESSION11,106 reports
DEATH5,511 reports
DIARRHOEA5,281 reports
FATIGUE4,772 reports
OFF LABEL USE4,418 reports
PYREXIA3,631 reports
RASH3,408 reports
PRODUCT USE IN UNAPPROVED INDICATION3,388 reports
NAUSEA3,336 reports
DECREASED APPETITE3,107 reports
HYPERTENSION2,982 reports
HYPOTHYROIDISM2,689 reports
ASTHENIA2,611 reports
PRODUCT USE ISSUE2,454 reports
DRUG INEFFECTIVE2,417 reports
Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.